Dewaraja YK[au] - Search Results

Year	Number of Results
2000	2
2001	1
2002	1
2005	1
2006	1
2007	2
2009	2
2010	4
2011	4
2012	3
2013	5
2014	4
2015	2
2016	1
2017	2
2018	6
2019	3
2020	8
2021	9
2022	9
2023	1

1

Toward Individualized Voxel-Level Dosimetry for Radiopharmaceutical Therapy.

Xiao Y, Roncali E, Hobbs R, James SS, Bednarz B, Benedict S, Dewaraja YK, Frey E, Grudzinski J, Sgouros G, Buchsbaum JC, Capala J. Xiao Y, et al. Among authors: dewaraja yk. Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):902-904. doi: 10.1016/j.ijrobp.2020.08.026. Int J Radiat Oncol Biol Phys. 2021. PMID: 33610302 No abstract available.

2

Recent advances in voxel-based targeted radionuclide therapy dosimetry.

Mok GSP, Dewaraja YK. Mok GSP, et al. Among authors: dewaraja yk. Quant Imaging Med Surg. 2021 Feb;11(2):483-489. doi: 10.21037/qims-20-1006. Quant Imaging Med Surg. 2021. PMID: 33532249 Free PMC article. No abstract available.

3

Advanced imaging and theranostics in thyroid cancer.

Roseland ME, Dewaraja YK, Wong KK. Roseland ME, et al. Among authors: dewaraja yk. Curr Opin Endocrinol Diabetes Obes. 2022 Oct 1;29(5):456-465. doi: 10.1097/MED.0000000000000740. Epub 2022 Jul 2. Curr Opin Endocrinol Diabetes Obes. 2022. PMID: 36068937 Review.

4

Transarterial Radioembolization for Hepatocellular Carcinoma and Hepatic Metastases: Clinical Aspects and Dosimetry Models.

Mikell JK, Dewaraja YK, Owen D. Mikell JK, et al. Among authors: dewaraja yk. Semin Radiat Oncol. 2020 Jan;30(1):68-76. doi: 10.1016/j.semradonc.2019.08.005. Semin Radiat Oncol. 2020. PMID: 31727302 Free PMC article. Review.

5

Reply: Single-Time-Point Tumor Dosimetry Assuming Normal Distribution of Tumor Kinetics.

Sgouros G, Dewaraja YK, Escorcia F, Graves SA, Hope TA, Iravani A, Pandit-Taskar N, Saboury B, James SS, Zanzonico PB. Sgouros G, et al. Among authors: dewaraja yk. J Nucl Med. 2022 May;63(5):804. doi: 10.2967/jnumed.121.263717. Epub 2022 Mar 10. J Nucl Med. 2022. PMID: 35273095 No abstract available.

6

Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns.

Sgouros G, Dewaraja YK, Escorcia F, Graves SA, Hope TA, Iravani A, Pandit-Taskar N, Saboury B, James SS, Zanzonico PB. Sgouros G, et al. Among authors: dewaraja yk. J Nucl Med. 2021 Dec;62(Suppl 3):12S-22S. doi: 10.2967/jnumed.121.262750. J Nucl Med. 2021. PMID: 34857617 Free article.

7

Dosimetry in patients with B-cell lymphoma treated with [(90)Y]ibritumomab tiuxetan or [(131)I]tositumomab.

Sjögreen-Gleisner K, Dewaraja YK, Chiesa C, Tennvall J, Lindén O, Strand SE, Ljungberg M. Sjögreen-Gleisner K, et al. Among authors: dewaraja yk. Q J Nucl Med Mol Imaging. 2011 Apr;55(2):126-54. Q J Nucl Med Mol Imaging. 2011. PMID: 21386787 Review.

8

Y-90 SIRT: evaluation of TCP variation across dosimetric models.

Van BJ, Dewaraja YK, Sangogo ML, Mikell JK. Van BJ, et al. Among authors: dewaraja yk. EJNMMI Phys. 2021 Jun 10;8(1):45. doi: 10.1186/s40658-021-00391-6. EJNMMI Phys. 2021. PMID: 34114115 Free PMC article.

9

A multicenter study on observed discrepancies between vendor-stated and PET measured ⁹⁰Y activities for both glass and resin microsphere devices.

Gnesin S, Mikell JK, Conti M, Prior JO, Carlier T, Lima TVM, Dewaraja YK. Gnesin S, et al. Among authors: dewaraja yk. J Nucl Med. 2022 Nov 23:jnumed.122.264458. doi: 10.2967/jnumed.122.264458. Online ahead of print. J Nucl Med. 2022. PMID: 36418169

10

Intra- and inter-operator variability in MRI-based manual segmentation of HCC lesions and its impact on dosimetry.

Covert EC, Fitzpatrick K, Mikell J, Kaza RK, Millet JD, Barkmeier D, Gemmete J, Christensen J, Schipper MJ, Dewaraja YK. Covert EC, et al. Among authors: dewaraja yk. EJNMMI Phys. 2022 Dec 21;9(1):90. doi: 10.1186/s40658-022-00515-6. EJNMMI Phys. 2022. PMID: 36542239 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results